Evid Based Nurs 8:49 doi:10.1136/ebn.8.2.49
  • Treatment

Fluconazole reduced the rate of recurrence of vulvovaginal candidiasis

 Q What is the efficacy of fluconazole for recurrent vulvovaginal candidiasis (VC)?



randomised placebo controlled trial.




blinded (patients and healthcare providers).

GraphicFollow up period:

12 months.


multiple centres in the US.


387 women ⩾18 years of age (mean age 34 y, 67% white) who had active, acute candida vaginitis (severity score ⩾3), a positive result on microscopic examination of vaginal secretions, ⩾4 episodes of candida vaginitis in the previous 12 months, and were clinically cured (severity score <3) at 14 days after receiving 3 sequential doses of fluconazole, 150 mg, at 72 hour intervals. Exclusion criteria: lack of confirmation of microscopic findings by culture, pregnancy, mixed infections or known seropositivity for HIV, or use of antifungal agents in the previous 4 weeks.


a single oral dose of fluconazole, 150 mg (n = 170),* or an oral placebo tablet taken weekly for 6 months (n = 173).*


clinical recurrence of …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article